Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Horst H Schlechte

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Annals of the New York Academy of Sciences|July 15, 2004
TP53 gene in blood plasma DNA of tumor patientsHorst H Schlechte, Cornelia Stelzer, Sabine Weickmann, et al.
Anticancer Research|June 25, 2003
Tissue polypeptide antigen (TPA) in comparison with mutations of tumour suppressor gene P53 (TP53) in patients with bladder cancerThorsten H Ecke, Severin V Lenk, Horst H Schlechte, et al.
Anticancer Research|April 9, 2005
Four tumour markers for urinary bladder cancer--tissue polypeptide antigen (TPA), HER-2/neu (ERB B2), urokinase-type plasminogen activator receptor (uPAR) and TP53 mutationThorsten H Ecke, Horst H Schlechte, Guntram Schulze, et al.
Urologic Oncology|March 28, 2008
Body mass index (BMI) and mutations of tumor suppressor gene p53 (TP53) in patients with urinary bladder cancerThorsten H Ecke, Horst H Schlechte, Sven Gunia, et al.
International Journal of Molecular Medicine|April 22, 2008
TP53 gene mutations as an independent marker for urinary bladder cancer progressionThorsten H Ecke, Markus D Sachs, Severin V Lenk, et al.
Anticancer Research|January 30, 2008
TP53 mutation in prostate needle biopsies--comparison with patients follow-upThorsten H Ecke, Horst H Schlechte, Anne Hübsch, et al.
Anticancer Research|July 2, 2010
TP53 gene mutations in prostate cancer progressionThorsten H Ecke, Horst H Schlechte, Katrin Schiemenz, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Annals of the New York Academy of Sciences|July 15, 2004
TP53 gene in blood plasma DNA of tumor patientsHorst H Schlechte, Cornelia Stelzer, Sabine Weickmann, et al.
Anticancer Research|June 25, 2003
Tissue polypeptide antigen (TPA) in comparison with mutations of tumour suppressor gene P53 (TP53) in patients with bladder cancerThorsten H Ecke, Severin V Lenk, Horst H Schlechte, et al.
Anticancer Research|April 9, 2005
Four tumour markers for urinary bladder cancer--tissue polypeptide antigen (TPA), HER-2/neu (ERB B2), urokinase-type plasminogen activator receptor (uPAR) and TP53 mutationThorsten H Ecke, Horst H Schlechte, Guntram Schulze, et al.
Urologic Oncology|March 28, 2008
Body mass index (BMI) and mutations of tumor suppressor gene p53 (TP53) in patients with urinary bladder cancerThorsten H Ecke, Horst H Schlechte, Sven Gunia, et al.
International Journal of Molecular Medicine|April 22, 2008
TP53 gene mutations as an independent marker for urinary bladder cancer progressionThorsten H Ecke, Markus D Sachs, Severin V Lenk, et al.
Anticancer Research|January 30, 2008
TP53 mutation in prostate needle biopsies--comparison with patients follow-upThorsten H Ecke, Horst H Schlechte, Anne Hübsch, et al.
Anticancer Research|July 2, 2010
TP53 gene mutations in prostate cancer progressionThorsten H Ecke, Horst H Schlechte, Katrin Schiemenz, et al.
Pageof 1